K-Bio Heading to the Middle East, Hosting the 'Advanced Regenerative Biopharmaceuticals Conference'

The Korea Health Industry Development Institute (KHIDI) announced on the 26th that it held the 'Korea-UAE Advanced Regenerative Biopharmaceuticals Conference (Medical Korea 2024 in the UAE)' on the 25th in Abu Dhabi, United Arab Emirates (UAE).

The 'Korea-UAE Advanced Regenerative Biopharmaceuticals Conference' is being held in Abu Dhabi, United Arab Emirates.
[Photo by Korea Health Industry Development Institute]

This event, organized by KHIDI, was hosted by the Embassy of the Republic of Korea in the UAE, the Abu Dhabi Department of Health, and the Abu Dhabi Stem Cell Center. It was also prepared in cooperation with the Pan-Governmental Regenerative Medicine Technology Development Project Group, the Safety Evaluation Research Institute, the Korea Biopharmaceutical Association, and the KDB Industrial Bank Abu Dhabi Branch.

Held under the theme "Innovation and Collaboration: New Horizons in Biohealth," the event was attended by over 300 local health policy officials and pharmaceutical distribution companies. Through presentations by 14 domestic companies and four cooperating organizations including KHIDI, the latest technologies and status of Korea's advanced regenerative biopharmaceuticals were introduced, and on the UAE side, speakers such as ▲Mohamed Al Bitar, Advisor at the Abu Dhabi Department of Health Research and Innovation Center ▲Amir Fazil, Consultant at the Abu Dhabi Stem Cell Center ▲Majed Al Musoti, Vice President of Adkan Pharmaceuticals participated to discuss cooperation and challenges between the UAE's advanced regenerative biopharmaceutical sector and Korea.

Separately, a promotional hall for domestic companies was set up where business consultations with UAE bio-related companies were held simultaneously. Korean companies participating in this event were able to confirm the potential for Korean advanced regenerative biopharmaceuticals to enter the UAE market through about 60 business meetings with over 40 local UAE industry representatives present on site.

Lee Young-ho, Head of KHIDI's UAE Branch, said, “Since the UAE government has a strong interest in acquiring new technologies in biopharmaceuticals and regenerative medicine and establishing domestic production bases, we hope this opportunity will be well utilized.”

This content was produced with the assistance of AI translation services.